Paulson & Co. - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 352 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.4%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$950,455,000
+42.4%
5,500,000
-5.3%
4.84%
+40.4%
Q4 2014$667,342,0005,806,0003.45%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Zurcher Kantonalbank (Zurich Cantonalbank) 173,845$7,037,0000.28%
AMUNDI ASSET MANAGEMENT US, INC. 537,900$21,774,0000.09%
NOMURA HOLDINGS INC 127,903$5,175,0000.06%
GOLDMAN SACHS GROUP INC 386,458$15,641,0000.01%
AQR Capital Management 26,000$1,052,0000.01%
GOLDMAN SACHS GROUP INC 100,000$4,047,0000.00%
RATIONAL ADVISORS LLC 288$12,0000.00%
HSBC HOLDINGS PLC 5,448$220,0000.00%
View complete list of SALIX PHARMACEUTICALS INC shareholders